LSE - Delayed Quote GBp

Kanabo Group Plc (KNB.L)

Compare
0.2250
-0.1600
(-41.56%)
At close: 3:51:51 PM GMT+1
Loading Chart for KNB.L
  • Previous Close 0.3850
  • Open 0.2500
  • Bid 0.1500 x --
  • Ask 0.2500 x --
  • Day's Range 0.2000 - 0.3700
  • 52 Week Range 0.2000 - 2.0000
  • Volume 1,831,642
  • Avg. Volume 459,825
  • Market Cap (intraday) 1.423M
  • Beta (5Y Monthly) 3.02
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Apr 28, 2025 - May 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well as develops and distributes cannabis derived medicinal and wellness products. Kanabo Group Plc was incorporated in 2016 and is based in London, the United Kingdom.

www.kanabogroup.com

20

Full Time Employees

December 31

Fiscal Year Ends

Recent News: KNB.L

View More

Performance Overview: KNB.L

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

KNB.L
73.53%
FTSE 100 (^FTSE)
5.76%

1-Year Return

KNB.L
87.50%
FTSE 100 (^FTSE)
2.64%

3-Year Return

KNB.L
96.38%
FTSE 100 (^FTSE)
1.99%

5-Year Return

KNB.L
95.16%
FTSE 100 (^FTSE)
35.02%

Compare To: KNB.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KNB.L

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    2.43M

  • Enterprise Value

    1.10M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.13

  • Price/Book (mrq)

    0.41

  • Enterprise Value/Revenue

    0.96

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -20.89%

  • Return on Equity (ttm)

    -83.19%

  • Revenue (ttm)

    1.14M

  • Net Income Avi to Common (ttm)

    -8.18M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.09M

  • Total Debt/Equity (mrq)

    3.49%

  • Levered Free Cash Flow (ttm)

    -852.88k

Research Analysis: KNB.L

View More

Company Insights: KNB.L

Research Reports: KNB.L

View More

People Also Watch